Home / Recalls / AEQUITA PHARMACY / D-0565-2025

D-0565-2025 Class II Ongoing

Recalled by AEQUITA PHARMACY — Kirkland, WA

Recall Details

Product Type
Drugs
Report Date
August 13, 2025
Initiation Date
July 18, 2025
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
158 vials

Product Description

Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

Reason for Recall

Lack of Processing Controls.

Distribution Pattern

MA

Code Information

All Lots within expiry.

Other recalls by AEQUITA PHARMACY

  • D-0561-2025 Class II — Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 (July 18, 2025)
  • D-0557-2025 Class II — Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 unit (July 18, 2025)
  • D-0556-2025 Class II — Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 unit (July 18, 2025)
  • D-0564-2025 Class II — Semaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol (July 18, 2025)
  • D-0562-2025 Class II — Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 (July 18, 2025)
  • D-0558-2025 Class II — Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 un (July 18, 2025)
  • D-0554-2025 Class II — Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units (July 18, 2025)
  • D-0563-2025 Class II — Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 un (July 18, 2025)
  • D-0553-2025 Class II — Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 (July 18, 2025)
  • D-0560-2025 Class II — Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 uni (July 18, 2025)